EA200401335A1 - CARBOXIMIDE DERIVATIVES AS UROSELECTIVE ALPHA-1A BLOCKERS OF ADDRESSORCEPTORS - Google Patents
CARBOXIMIDE DERIVATIVES AS UROSELECTIVE ALPHA-1A BLOCKERS OF ADDRESSORCEPTORSInfo
- Publication number
- EA200401335A1 EA200401335A1 EA200401335A EA200401335A EA200401335A1 EA 200401335 A1 EA200401335 A1 EA 200401335A1 EA 200401335 A EA200401335 A EA 200401335A EA 200401335 A EA200401335 A EA 200401335A EA 200401335 A1 EA200401335 A1 EA 200401335A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- addressorceptors
- uroselective
- blockers
- alpha
- carboximide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Предложены новые производные карбоксимида, которые селективно ингибируют связывание с α-адренорецептором, играющим важную роль в лечении доброкачественной гиперплазии простаты. Соединения по настоящему изобретению являются потенциально пригодными для лечения доброкачественной гиперплазии простаты.Международная заявка была опубликована вместе с отчетом о международном поиске.New carboximide derivatives have been proposed that selectively inhibit the binding to the α-adrenoreceptor, which plays an important role in the treatment of benign prostatic hyperplasia. The compounds of the present invention are potentially useful in treating benign prostatic hyperplasia. The international application was published along with an international search report.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2002/001108 WO2003084541A1 (en) | 2002-04-08 | 2002-04-08 | Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200401335A1 true EA200401335A1 (en) | 2006-02-24 |
Family
ID=28686909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200401335A EA200401335A1 (en) | 2002-04-08 | 2002-04-08 | CARBOXIMIDE DERIVATIVES AS UROSELECTIVE ALPHA-1A BLOCKERS OF ADDRESSORCEPTORS |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1494674A4 (en) |
JP (1) | JP2005532282A (en) |
CN (1) | CN1627946A (en) |
AU (1) | AU2002251409A1 (en) |
BR (1) | BR0215686A (en) |
EA (1) | EA200401335A1 (en) |
MX (1) | MXPA04009821A (en) |
WO (1) | WO2003084541A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005018643A1 (en) * | 2003-08-25 | 2005-03-03 | Ranbaxy Laboratories Limited | Metabolites of 1-{3-4`4-(2-methoxyphenyl) piperazin-1-yl!-propyl}-piperidine-2, 6-dione for use in the treatment of benign prostatic hyperplasia |
WO2005037281A1 (en) * | 2003-10-15 | 2005-04-28 | Ranbaxy Laboratories Limited | 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ315098A3 (en) * | 1996-04-05 | 1999-04-14 | Société De Conseils De Recherches Et D'applications Scientifiques (S. C. R. A. S.) | Antagonists of alpha1-adrenergic receptors |
IT1293807B1 (en) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | 1- (N-PHENYLAMINOALKYL) PIPERAZINE DERIVATIVES SUBSTITUTED AT POSITION 2 OF THE PHENYL RING |
US6083950A (en) * | 1997-11-13 | 2000-07-04 | Ranbaxy Laboratories Limited | 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers |
FR2781220B1 (en) * | 1998-07-17 | 2000-10-13 | Lafon Labor | SUBSTITUTED BETA PIPERAZINONES |
-
2002
- 2002-04-08 AU AU2002251409A patent/AU2002251409A1/en not_active Abandoned
- 2002-04-08 CN CNA028290976A patent/CN1627946A/en active Pending
- 2002-04-08 MX MXPA04009821A patent/MXPA04009821A/en not_active Application Discontinuation
- 2002-04-08 JP JP2003581781A patent/JP2005532282A/en not_active Withdrawn
- 2002-04-08 WO PCT/IB2002/001108 patent/WO2003084541A1/en active Application Filing
- 2002-04-08 BR BR0215686-5A patent/BR0215686A/en not_active IP Right Cessation
- 2002-04-08 EA EA200401335A patent/EA200401335A1/en unknown
- 2002-04-08 EP EP02720343A patent/EP1494674A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MXPA04009821A (en) | 2004-12-13 |
WO2003084541A1 (en) | 2003-10-16 |
EP1494674A1 (en) | 2005-01-12 |
BR0215686A (en) | 2005-02-22 |
EP1494674A4 (en) | 2006-04-12 |
JP2005532282A (en) | 2005-10-27 |
CN1627946A (en) | 2005-06-15 |
AU2002251409A1 (en) | 2003-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200600689A1 (en) | SUBSTITUTED BENZEZOLES AND THEIR APPLICATION AS RAF KINASE INHIBITORS | |
DE602004006433D1 (en) | PYRROL SUBSTITUTED INDOLE AS INHIBITORS OF PAI-1 | |
EA200601766A1 (en) | Imidazole Derivatives | |
ATE554087T1 (en) | NEW KINASE INHIBITORS | |
EA200300793A1 (en) | DERIVATIVES 3- (4-AMIDOPIRROL-2-ILMETYLIDENE) -2-INDOLINON AS PROTEKINKINAZ INHIBITORS | |
EA200602100A1 (en) | COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION | |
ATE541571T1 (en) | DIARYLHYDANTOIN COMPOUND | |
BG66084B1 (en) | Cyclopentanoindoles, compositions containing such compounds and their use | |
EA201100427A1 (en) | HETEROCYCLIC KINASE INHIBITORS | |
EA200601553A1 (en) | SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES | |
EA200800374A1 (en) | 1,4-DIHYDROPYRIDIN-CONDENSED HETEROCYCLES, METHODS FOR THEIR PRODUCTION, USE AND CONTAINING COMPOSITIONS | |
EA200501928A1 (en) | Pyrrolodihydroisoquinols as inhibitors of PDE10 | |
ECSP067099A (en) | COMPOUNDS AND METHODS TO INHIBIT THE INTERACTION OF BCL PROTEINS WITH LINK COMPONENTS | |
ATE484508T1 (en) | FURYL COMPOUNDS | |
EA200702110A1 (en) | BCRP / ABCG2 INHIBITOR | |
MX2010003365A (en) | Thiazol derivatives for treating cancer. | |
ATE510822T1 (en) | POTASSIUM CHANNEL INHIBITORS | |
MXPA05013076A (en) | Isoindolin-1-one compounds as kinase inhibitors. | |
DK1373220T3 (en) | Benzimidazoles which are useful in the treatment of sexual dysfunction | |
ATE430148T1 (en) | NEW PYRROLODIHYDROISOCHINOLINES AS PDE10 INHIBITORS | |
ATE549024T1 (en) | QUINAZOLINE POTASSIUM CHANNEL INHIBITORS | |
ATE302002T1 (en) | USE OF PYRAZOLE DERIVATIVES TO TREAT INFERTILITY | |
DE602005010258D1 (en) | TREATMENT OF BALLAST WATER | |
ATE419242T1 (en) | PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS | |
DE60329326D1 (en) | TACE INHIBITORS |